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Abstract.  Affinity-purified polyclonal antibodies were 
used to quantitate steady-state levels of DNA 
topoisomerase II (topo H) throughout Drosophila de- 
velopment.  Although wide fluctuations were recorded 
at different stages, these fluctuations were paralleled 
by changes in levels of the nuclear lamin,  a nuclear 
structural protein used as an internal  standard.  The 
exception to this was adult males where lamin levels 
were significantly elevated relative to topo II.  North- 
ern blot analyses of topo II and lamin mRNA, per- 
formed in conjunction with immunoblot analyses of 
protein revealed fluctuations in levels of the two differ- 
ent messages that paralleled changes in each other and 
in their respective translation products.  Biochemical 
and immunochemical analyses were complemented by 
indirect immunofluorescence and immunoperoxidase 
experiments performed in situ.  topo II was found dis- 
tributed throughout nuclei in most but not all cell 
types examined.  These results for Drosophila topo II 
are apparently at odds with those obtained by others 
working in vertebrate systems (see, for example, Heck, 
M.  M.  S. and W. C.  Earnshaw.  1986. J.  Cell Biol. 
103:2569-2581;  Heck, M.  M.  S., W. N. Hittelman, 
and W. C.  Earnshaw.  1988.  Proc. Natl. Acad.  Sci. 
USA. 85:1086-1090) and suggest that in Drosophila, 
topo II may not be a useful marker for the prolifera- 
tive state. 
NA topoisomerase II (topo 11)~ is an enzyme that in 
vitro, catalyzes the ATP-dependent double-stranded 
breakage and rejoining  of duplex DNA (for review, 
see Wang, 1985). In vivo, the function or functions of topo 
II are not fully understood (for a  review,  see Sternglanz, 
1989).  Genetic  studies  in both Saccharomyces cerevisiae 
(DiNardo et al.,  1984; Holm et al.,  1985) and Schizosac- 
charomyces pombe (Uemura and Yanagida,  1984) demon- 
strated that topo IT was essential; cells lacking enzymatically 
active topo II arrested in mitosis and subsequently died.  It 
was suggested that this might be due to the inability of cells 
deficient  in topo II to resolve multiply intertwined  DNA 
catenanes resulting from termination  of replication (see also, 
Sundin  and  Varshavsky, 1980;  Sundin  and  Varshavsky, 
1981). Other results indicate that topo II may be important 
in  transcription  (Brill  et al.,  1987; Brill  and  Sternglanz, 
1988). 
It also has been suggested that topo II plays a structural 
(karyoskeletal) role in organizing both mitotic chromosomes 
and interphase  nuclei (for a review, see Fisher,  1988). topo 
II is a major component of mitotic chromosomes and mitotic 
chromosome scaffold fractions (Earnshaw et al., 1985; Gas- 
ser et al., 1986) as well as interphase-derived  karyoskeletal 
protein-enriched fractions  from Drosophila (Berrios et al., 
1985; McConneU et al., 1987) and yeast (Berrios and Fisher, 
1988;  Cardenas  et  al.,  1990).  Moreover,  specific  DNA- 
1. Abbreviations  used in this paper: PCNA, proliferating cell nuclear anti- 
gen; topo II, DNA topoisomerase II. 
scaffold attachment  sites mapped in several systems  have 
been found to be enriched  in the consensus cleavage  se- 
quence defined by Sander and Hsieh (1985) for Drosophila 
topo II (for reviews,  see Mirkovitch  et al.,  1987; Fisher, 
1989). 
Recently,  the  finding  that  nondividing  vertebrate cells, 
i.e.,  those in phase Go of the cell cycle,  apparently  lack 
topo II (Heck and Earnshaw,  1986; Heck et al., 1988) raised 
concerns about the generality  of topo IFs role in organizing 
the interphase  nucleus.  Results of a developmental  survey 
performed in Drosophila (Fairman and Brutlag,  1988) were 
interpreted as being consistent with the hypothesis that topo 
II was either absent or substantially  reduced in nondividing 
cells of this organism  as well. However, our initial impres- 
sions based on indirect immunofluorescence  analyses (Ber- 
rios et al., 1985; McConnell et al., 1987) were contrary to 
the notion that Drosophila topo II was absent from any par- 
ticular cell or cell type in third instar larvae, a stage at which 
many  of the cells would be expected to be nondividing. 
Moreover,  the developmental  fluctuations  in topo II levels 
reported by Falrman  and Brutlag  (1988) were reminiscent 
of those we had observed for Drosophila lamins  (unpub- 
lished data). In the case of lamins, these fluctuations seemed 
to reflect inversely, fluctuations  in the levels of nonnuclear 
proteins (e.g., muscle proteins such as actin and myosin) and 
correlated directly with the relative reduction in the numbers 
of nuclei as reflected by the decreasing  DNA/protein ratio 
(Robertson,  1978). 
To investigate further the expression of Drosophila topo II 
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levels of topo 1I mRNA  and protein with levels of lamin 
mRNA  and protein,  respectively.  Indirect immunofluores- 
cence and immunoperoxidase analyses were used to study 
the  distribution  of these  two proteins  in  situ.  From  our 
results, we conclude that with the exception of adult males, 
both topo II and lamin are present at relatively constant lev- 
els throughout  development;  topo II is found in nuclei of 
most but not all cell types examined. 
Materials and Methods 
Antibodies 
Affinity-purified goat anti-rabbit IgG was from Cappel Laboratories (Mal- 
vern, PA). Rhodamine-conjugated  affinity-purified  donkey anti-rabbit IgG 
was from Jackson Inununo Research Laboratories Inc. (West Grove, PA). 
Biotinylated goat  anti-rabbit IgG  was  from  Vector  Laboratories,  Inc. 
(Burlingame,  CA).  Anti-Drosophila  lamin antibodies (see,  for example, 
Smith and Fisher, 1989), anti-Drosophila muscle myosin heavy chain anti- 
bodies (Berrios and Fisher,  1986),  and anti-Drosophila proliferating  cell 
nuclear antigen (PCNA) antibodies (Ng et al., 1990) were affinity purified 
essentially  according to Fisher and Smith (1988). Anti-Drosophila topo II 
antiserum was prepared previously (McConnell et at., 1987) and anti-tope 
II antibodies were affinity purified using a fragment of Drosophila topo II 
that had been expressed in Escherichia  coil,  purified,  and coupled to 
glutaraldehyde-activated  glass beads (Boehringer Mannheim, Diagnostics, 
Inc., Indianapolis,  IN) as detailed in Results. 
Me~o~ 
Much of the methodology has been detailed previously. Drosophila melano- 
gaster (Oregon R, P2 strain) were maintained in mass culture and embryos 
harvested according to Allis et at. (1977).  Protein determination was ac- 
cording to Schaff-ner and Weissman (1973).  $DS-PAGE was on 7% poly- 
acrylamide gels according to Laemmli (1970).  Proteins were transferred 
passively from SDS-gels to sheets of nitrocellulose (Fisher et at., 1982) and 
resulting immunoblots were processed, probed with primary antibodies, 
and  bands  of  reactivity  visualized  colorimetrically  with  calf alkaline 
phosphatase-conjugated goat anti-rabbit IgG secondary antibodies (Blake 
et al., 1984; Smith and Fisher, 1984). Calf alkaline phosphatase was con- 
jugated to afffinity-purified goat anti-rabbit IgG according to Avrameas 
(1969);  colorimetric detection was according to McGadey (1970).  Addi- 
tional details are provided in the figure legends. 
Northern Blot Analyses 
RNA was prepared from Drosophila embryos, larvae, pupae, and adults es- 
sentially  according to O'Connell et at. (1987) using a combined method 
involving guanidinium thiocyanate  extraction (Chirgwin et at.,  1979) and 
CsC1 purification (Gli§in et al., 1974). Organisms were quick-frozen in liq- 
uid N2, pulverized with a mortar and pestle, and then extracted with 4 M 
guanidinium thiocyanate,  1 M 2-mercaptoethanol, 50 mM sodium acetate 
pH 6, and 5 mM Na2EDTA. Crude extracts were clarified by centrifuga- 
tion for 10 min at 1,000 g; '~2 ml of clarified extract was layered over a 
4-ml cushion of 5.7 M CsCi, 0.1 M Na2EDTA, and the extractwas cen- 
trifuged at 15"C for 24 h at 35,000 rpm in an SW41 rotor. The clear RNA 
pellet was dissolved in 10 mM Tris-HCl pH 7.5, 5 mM Na2EDTA, and 
1%  SDS,  extracted once with an equal volume of chloroform:l-butanol 
(4:1),  ethanol precipitated,  and the precipitate resolubilized in diethyl 
pyprocarbonate (DEPC) treated H20. 
Hybridization of radiolabeled DNA probes to immobilized RNA was 
performed essentially according to Thomas (1980). RNA was denatured in 
formaldehyde and subjected to electrophoresis on horizontal 0.8% agarose 
slab gels containing 6% formaldehyde  exactly as previously described in 
detail (Gruenbaum et at.,  1988). After electrophoresis,  gels were washed 
for 1 h in 10× SSC (1× SSC is 150 mM NaCI,  15 m_M sodium citrate pH 
7.0) to remove formaldehyde and separated RNA species were transferred 
passively to Nytran (Schleicher & Scheull, Inc., Keene, NH) for 20 h using 
10× SSC. After transfer, the blot was washed briefly in 10x SSC and the 
RNA  was  permanently  immobilized by  UV  cross-linking.  Blots  were 
probed and washed exactly  as previously  described (Gruenbaum et at., 
1988)  using 32P-labeled DNA probes generated by the random priming 
method of Feinberg and Vogelstein (1983). Generally,  the probes were la- 
beled to a specific activity  of ,05  x  l0  s cpm/#g of DNA. 
Quantitation of  lmmunoblots and Northern Blots 
Bands of immunoblot reactivity were quantitated by excising regions of in- 
terest from the nitrocellulose and incubating them in DMSO. This results 
both in dissolution of the nitrocellulose  and in solubilization  of the purple 
phosphatase reaction product present on the immunoblot.  The resulting 
DMSO-phosphatase  reaction  product  solution  was  subjected  to  spec- 
trophotometric analysis at 540 nm. We previously  demonstrated immuno- 
blot reactivity to be linearly dependent on antigen concentration (Smith and 
Fisher,  1984),  and in a  series of control experiments  performed  with 
purified Drosophila lamin, showed that the DMSO soluhilization  method 
of immunoblot quantitation gave identical  results to quantitation of lamin 
protein in solution (Fisher, P., unpublished data). This method of immuno- 
blot quantitation, as opposed to conventional  scanning densitometry,  was 
necessary due  to  the substantial variation in absolute amounts  of im- 
munoreactivity as well as in band morphology in the various lanes being 
analyzed (see Fig.  2). 
Northern blot reactivity was quantitated by integrative  scanning den- 
sitometry of autoradiograms. This was performed using an ULTROSCAN 
XL laser densitometer (LKB Instruments Inc., Galthersburg,  MD). Addi- 
tional details are provided  in the legend to Fig.  5. 
lmmunocytochemistry 
Indirect immunofluorescence  microscopy  using third instar larval  squash 
preparations and cryosections  was performed essentially  as previously de- 
scribed (Fisher et at., 1982; Smith and Fisher, 1984) and as follows. Muscle 
cell squash preparations were from adult fly thoraces. All whole tissue 
squashes were prepared in buffer A as originally described by Burgoyne et 
al. (1971; see also Paddy et al,, 1990) supplemented with 0.1% Triton X-100 
and 3.7 % formaldehyde. Adult fly heads were dissected manually, prepared 
for cryosectioning,  and cryosections  cut as previously described for whole 
third instar larvae (Smith and Fisher,  1984). Because of intense autofluores- 
cence,  specific antibody binding to adult head cryosections  was detected 
using a biotinylated secondary antibody followed by incubation with avidin- 
complexed biotiuylated horseradish peroxidase  and appropriate developing 
reagents as specified in the VECTASTAIN ABC Elite kit (Vector Laborato- 
ties, Inc.). 
Preparation of Whole Organismal Extracts and 
Cell Fractionation 
Whole embryo extracts  were prepared by Dounce homogenization  of de- 
velopmentally staged embryos directly into 10 vol of boiling 10% SDS, 20 
mM DTT. Boiling after homogenization  was continued for "o3 rain. Whole 
organismal extracts  from larvae, pupae,  and adults were prepared by first 
freezing in liquid N2 followed by grinding to a fine powder under liquid N2 
with a mortar and pestle. The liquid N2 was allowed to evaporate and "ol0 
vol of boiling 10% SDS, 20 mM DTT was added.  Boiling was continued 
for about 3 rain immediately thereafter.  After cooling, boiled extracts were 
clarified by centrifugation and either used immediately or stored at -20°C. 
For  cell  fractionation experiments,  developmentally  staged  embryos 
were Dounce homogenized into standard extraction buffer  (Fisher et at., 
1982; McConnell et at., 1987) and homogenates subjected to centrifugation 
for  10 rain at 10,000 g.  Pellet fractions were  resuspended in extraction 
buffer. Supernatants,  resuspended pellets, and aliquots of the unfractionated 
homogenates were denatured by addition of an equal volume of 20% SDS, 
40 mM DTT and boiling for ,o3 rain immediately  thereafter. 
Results 
Specificity of  Anti-topo II Antibodies 
To determine reliably the levels of nuclear proteins in crude 
extracts  by immunoblot analysis as well as to study their in 
situ localization by indirect immunofluorescence and/or im- 
munoperoxidase staining, highly specific antibodies are re- 
quired. A strategy  which proved effective for obtaining suit- 
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sophila topo II and affÉnity  purification 
of  anti-topo  II  antibodies.  E.  coli 
BL21(DE3)  cells  harboring  bacterio- 
phage T7 gene  1 coding for T7 RNA 
polymerase under control of  the lacUV5 
promoter (see Studier et al., 1990) were 
transformed with pET3a  alone (A) or 
pET3DT2 (B), a pET3a derivative con- 
taining a eDNA insert encoding amino 
acids 32-1447  of Drosophila topo II. 
SDS-7  % PAGE  was on minigels (Hoefer 
Scientific Instruments,  San  Francisco, 
CA); gels  as  indicated,  were  stained 
with Coomassie blue; blots as indicated, 
of parallel gels were probed with anti- 
Drosophila topo II antiserum prepared 
against the native enzyme (see Berrios et 
al., 1985) diluted 1:1,000. For both gels 
and blots, A and B; lanes a, before induc- 
tion; lanes b, 0.5 h after induction with 
0.4 mM IPTG; lanes c, 1 h after induc- 
tion; lanes d, 2 h after induction. Down- 
pointing  arrowhead  in  B  gel,  lane  d 
designates  the  new  Coomassie  blue- 
stainable protein band seen after induc- 
tion only in cells harboring pET3DT2. 
The apparent mass of this polypeptide, 
,,o120 kD, is smaller than expected based 
on the size of the topo I/eDNA insert; 
this likely results either from premature 
termination  of translation  and/or  pro- 
teolysis. Arrowheads to the left of gels 
in both A and B designate migration po- 
sitions of (from top to bottom) t~2 mac- 
roglobulin  (170 kD),  ~-galactosidase 
(116 kD),  phosphorylase  b  (97  kD), 
BSA (69 kD),  ovalbumin (46 kD),  and 
carbonic anhydrase (30 kD). Arrowheads to the right of blots in both A and B designate migration positions of (from top to bottom) myosin 
heavy chain (200 kD), B-galactosidase, phosphorylase b, and BSA. (C) Affinity purification of anti-Drosophila topo II antibodies. Nitro- 
cellulose strips containing Drosophila nuclear proteins transferred after separation on a 20-cm-long SDS-7% polyacrylamide gel were 
probed either with unfractionated anti-Drosophila topo II antiserum diluted 1:1,000 (S), or with a comparable amount of anti-Drosophila 
topo 1] IgG purified by affinity chromatography on immobilized bacterially synthesized Drosophila topo II (AP). Minor bands below the 
main band on strip AP represent commonly encountered topo II proteolytic breakdown products (see, for example, Berrios et al., 1985). 
able anti-lamin antibodies involved preparation of a rabbit 
antiserum by immunization with authentic  lamin  purified 
from Drosophila  embryos followed by affinity purification 
using as the immobilized affinity ligand, clone-encoded anti- 
gen expressed in bacteria (see, for example, Gruenbaum et 
al., 1988; Fisher and Smith, 1988; Smith and Fisher, 1989). 
To pursue a similar strategy for affinity purification of  anti- 
topo II antibodies, a  full-length Drosophila  topo II cDNA 
clone (Nolan et al., 1986) was obtained from Dr. T.-s. Hsieh 
(Duke  University,  Durham,  NC).  In  preliminary  experi- 
ments, we demonstrated that the in vitro translation product 
synthesized in a wheat germ lysate after transcription of this 
clone could be specifically immunoprecipitated (not shown) 
by either of two anti-tope II antisera available in the labora- 
tory (see McCormell et al.,  1987) as well as by anti-topo II 
antibodies affinity purified using authentic Drosophila topo 
II as the affinity ligand (see Berrios et al.,  1985). A 4.6-kb 
Barn HI fragment of the topo II eDNA, encoding all but a 
small portion of the NH2 terminus of topo U (amino acids 
32-1,447; Wyckoff  et al., 1989) was ligated in frame into the 
T7 RNA polymerase-dependent expression vector, pET3a 
(Rosenberg et al., 1987; Studier et al., 1990) to generate the 
plasmid pET3DT2. An  appropriate strain of bacteria was 
transformed either with this plasmid or with a control plas- 
mid lacking the topo II eDNA insert. Transformed cultures 
were induced with isopropyl/3-D-thiogalactoside (IPTG) and 
after various periods,  cells were lysed, and proteins sub- 
jetted to SDS-PAGE and immunoblot analysis with anti-topo 
II antiserum. 
When ceils were transformed with the control plasmid, 
there was no change in the Coomassie blue staining pattern 
during the time course of induction (Fig.  1 A, gel) nor were 
any immunoreactive polypeptides detectable on a  parallel 
immunoblot probed with anti-topo II antiserum (Fig.  1 A, 
blot).  In  contrast,  induction  of  ceils  transformed  with 
pET3DT2 resulted in synthesis of a new polypeptide as de- 
termined by Coomassie blue staining (Fig.  1 B, gel); this 
polypeptide was highly reactive with anti-topo II antiserum 
(Fig. 1 B, blot). This bacterially synthesized polypeptide was 
purified from cell extracts under denaturing conditions (see 
Whaten et al. Developmental Regulation of topo H  205 Figure 2. Steady-state levels of topo H, nuclear lamin, and muscle 
myosin  heavy chain during Drosophila development. Extracts were 
prepared as described (Materials and Methods), and 500-/tg ali- 
quots of each subjected to electrophoresis on 20-cm-long SDS-7  % 
polyacrylamide  gels. After  electrophoresis,  separated  proteins 
were transferred passively (Fisher et al.,  1982) to nitrocellulose 
and resulting immunoblots were probed with specific antibodies. 
Only primary regions of reactivity are shown. The blot shown in A 
was probed with antiserum raised against native Drosophila topo 
II diluted 1:1,000; identical results were obtained using comparable 
amounts  of  affinity-purified anti-Drosophila topo  II  IgG  (not 
shown). The blot shown in B was probed with affinity-purified  anti- 
Drosophila lamin  IgG.  The blot  shown in  C was probed  with 
affinity-purified anti-Drosophila muscle myosin heavy chain IgG. 
Samples loaded  in individual lanes were the  same in all three 
panels; lanes a, 0--3-h-old embryos; lanes b, 6-9-h-old  embryos; 
lanes c, 12-15-h-old  embryos; lanes d, 19-22-h-old embryos; lanes 
e, first instar larvae; lanes  f, second instar larvae; lanes g, third in- 
star larvae; lanes h, pupae; lanes i, male adults; lanes j, female 
adults. 
Filson  et  al.,  1985),  coupled to  glutaraldehyde-activated 
glass beads and used as a ligand for affinity purification of 
anti-topo  II  antibodies  (Fig.  1  C).  All  subsequent  im- 
munochemical and immunocytochemical experiments were 
either performed or corroborated using anti-topo II antibod- 
ies affinity purified in this way. 
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Figure 3. Quantitative analysis of  immunoblots shown in Fig. 2. Im- 
munoreactivity on blots shown in Fig. 2 was quantitated (Materials 
and Methods) by excision of individual hands from the nitrocellu- 
lose, dissolution in DMSO, and spectrophotometric analysis at 540 
nm using an enzyme immtmoassay  microtitre plate reader (Bio-Tek 
Instruments Model EL-308). Designations (a-j) of developmental 
stage as indicated along the abscissa, correspond respectively, to 
lane headings (a-j) as indicated in legend to Fig. 2. A, B, and C 
correspond to A, B, and (7, respectively, of Fig. 2; (A) topo II; (B) 
total lamin (all isoforms); (C) muscle myosin heavy chain. 
Developmental Regulation of topo H Protein and 
mRNA Levels 
topo II levels throughout Drosophila development were de- 
termined by quantitative immunoblot analysis  (Smith and 
Fisher, 1984) and were compared with levels of lamin  2 and 
muscle myosin heavy chain. At first appro  "xtmation, fluctua- 
tions  in  topo  II  levels  (Fig.  2  A)  were  similar  to  those 
reported previously (Fairman and Brutlag, 1988). However, 
comparable fluctuations in lamin levels were also seen (Fig. 
2 B). In contrast, muscle myosin heavy chain, a nonnuclear 
protein, showed an entirely different pattern of expression 
through development (Fig. 2  C). 
The immunoblots shown in Fig. 2 were analyzed quantita- 
tively (Materials and Methods) and the results are presented 
graphically in Fig. 3. In general, these results confirm im- 
2.  Unlike vertebrates  where  multiple,  developmentally  regulated  lamins 
have been reported, Drosophila has only a single lamin gene encoding a sin- 
gle primary  translation  product  (Smith et al.,  1987; Gruenbaum  et al., 
1988). This  single lamin gene is expressed throughout development and 
immunocross-reactive isoforms derived from the single primary translation 
product by posttranslational  modification have been identified at all stages 
of development and in every cell and tissue type analyzed (Fisher,  1988). 
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of topo  II  and  lamin  mRNAs 
during Drosophila development. 
RNA was prepared as described 
(Materials and Methods) and 30 
~tg of total RNA from each de- 
velopmental  stage  was  eleetro- 
phoresed  on  a  0.8%  agarose 
gel, transferred passively to Ny- 
tran,  and probed with randomly 
primed  32p-labeled cDNA  frag- 
ments  complementary  to  either 
Drosophila topo II mRNA (A and 
C) or Drosophila lamin mRNA 
(B). Arrowheads to the left of A 
designate the migration positions 
of 6.6- (top) and 4.4-kb (bottom) 
lambda Hind HI fragments used 
as markers. Arrowhead to the left 
of B designates the migration po- 
sition of the 2.3-kb lambda Hind 
HI  fragment used  as  a  marker. 
RNA aliquots from identical de- 
velopmental  stages, loaded  on 
the gels represented in A and B, 
were; lanesa, 0-3-h-old  embryos; 
lanes b, 6-9-h-old embryos; lanes 
c, 12-15-h-old embryos; lanes d, 
19-22-h-old  embryos;  lanes  e, 
first instar larvae; lanes f, second 
instar larvae; lanes g, third instar 
larvae; lanes h, pupae; lanes i, to- 
tal adults (males plus  females). 
(C)  Similar  analysis  to  that 
shown in A; lane a, adult males; 
lane b, adult females; lane c, total 
adults (males plus females). 
pressions obtained from visual inspection of the immuno- 
blots in Fig. 2. The only significant deviation between levels 
of  topo II and lamin noted in examining the quantitative data 
in Fig. 3 occurred with adult males. Whereas males and fe- 
males had similar absolute levels of lamins (Fig. 3 B, com- 
pare i and j), males had markedly reduced levels of topo II 
relative to females (Fig. 3 A, compare i and j). That the low 
levels of topo II detectable in males were indeed reproduci- 
bly present was confirmed by repeated analyses (not shown). 
Developmental immunoblot analyses of topo II and lamin 
protein levels were complemented by Northern blot experi- 
ments to determine relative mRNA levels, topo II mRNA 
was detected at all developmental stages although barely so 
in larvae (Fig. 4 A). Longer exposure of the Northern blot 
shown in Fig. 4 A confirmed the existence of the faint bands 
of radioactivity in lanes e, f, and g (not shown, but see Fig. 
5 A). Comparison oftopo II mRNA levels with lamin mRNA 
levels (Fig. 4 B) is complicated by the fact that there are two 
developmentally regulated lamin messages both coding for 
the same primary translation product (Gruenhaum et al., 
1988). Nevertheless, it can be seen from the data in Fig. 4 
that topo II mRNA  levels varied through development in 
roughly the same way as did total lamin mRNA levels. The 
most  conspicuous  difference was  early in  embryogenesis 
when lamin mRNA  levels increased over the first several 
hours before beginning to decrease at the final time point, 
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Figure 5. Quantitative analysis of Northern blots shown in Fig. 4. 
Quantitative  densitometric analysis  of Northern blots shown  in Fig. 
4 was performed on an LKB ULTROSCAN  XL Laser Densitome- 
tar (Materials and Methods). Units of absorbance are arbitrary. 
Designations (a-i) of developmental stage as indicated along the 
abscissa, correspond respectively, to lane headings (a-i) as indi- 
cated in Fig. 4. A and B correspond to A and B, respectively,  of Fig. 
4; (A) topo II mRNA; (B) total lamin mRNA (both 2.8- and 3.0-kb 
species). 
whereas topo II mRNA levels  were highest at the earliest 
time point of embryogenesis analyzed. Quantitative densito- 
metric analysis of the Northern blots shown in Fig. 4, A and 
B is shown in Fig. 5. These results confirmed impressions 
obtained from visual inspection of the respective autoradio- 
grams. 
The preponderance of topo II mRNA early in embryogen- 
esis was consistent with the notion that large amounts of this 
message were accumulated and stored during oogenesis. We 
previously reported that this was apparently the explanation 
for the predominance of the 2.8 kb (as opposed to the 3.0 kb) 
lamin mRNA early in embryogenesis (Gruenbaum et al., 
1988). To evaluate this possibility for topo II, adult Drosoph- 
ila males and females were segregated and total RNA from 
each group analyzed separately. Results from this experi- 
ment (Fig. 4 C) demonstrated that while topo II mRNA was 
detectable in both males and females, much more of  the mes- 
sage was found in females. 
In Situ Identification of topo H in Various Drosophila 
Cells and 1issues 
Developmental immunoblot and Northern blot experiments 
were  complemented by indirect immunofluorescence and 
immunoperoxidase analyses performed on selected larval 
and adult tissues. Results of some of these experiments are 
shown in Figs. 6 and 7. Initially, examination of third instar 
larval cryosections that were labeled with afffinity-purified 
anti-topo II IgG revealed specific nuclear staining in virtu- 
ally all cells; a representative field is shown in Fig. 6, a-c. 
All nuclei identified by DAPI staining (Fig. 6 c) were also 
stained to greater or lesser degree with anti-topo II antibod- 
ies (Fig. 6 b). This was consistent with results obtained pre- 
viously with unfractionated anti-topo II antiserum (McCon- 
nell et al.,  1987). 
Squash preparations of various third instar larval tissues 
and organs, including salivary gland, imaginal disc, and neu- 
ral ganglion, were also examined by indirect immunofluores- 
cence analysis using affinity-purified  anti-topo II antibodies. 
As in cryosections, and consistent with results obtained pre- 
viously with unfractionated anti-topo II antiserum (Berrios 
et al., 1985), virtually all nuclei identifiable by DAPI stain- 
ing were labeled with affinity-purified anti-topo II antibod- 
ies. An example of results obtained with neural ganglion tis- 
sue is shown in Fig. 6, d-f 
Recently, we reported the identification and purification of 
Drosophila  PCNA; Drosophila  PCNA is structurally and 
functionally  homologous to mammalian PCNA, and was de- 
tectable by immunofluorescence  analysis in only a small sub- 
set of third instar larval neural ganglion cells (Ng et al., 
1990). 3 This  staining  pattern,  an  example  of  which  is 
shown in Fig. 6, g-i, is in marked contrast to that seen with 
anti-topo II antibodies (Fig. 6, d-f). 
Additional immunocytochemical experiments were per- 
formed with adult tissues. Hadlaczky et al. (1988) reported 
the presence of topo II in fly heads as determined by immu- 
noblot analysis with monoclonal antibodies. To complement 
these  immunochemical data and to  establish  further the 
presence of  topo II in nonproliferating cells, we used afffinity- 
purified polyclonal anti-topo II antibodies for immunocyto- 
chemical analysis of adult head cryosections. Because of in- 
tense autofluorescence, these sections were probed with a 
peroxidase-coupled secondary reagent (Materials and Meth- 
ods). Results of this analysis demonstrated the presence of 
topo II in most if not all nuclei identifiable (not shown). 
No specific staining was seen either in control specimens or 
in specimens probed with affinity-purified anti-PCNA anti- 
bodies (not shown). Results similar to those obtained with 
anti-topo II antibodies were noted when specimens were 
probed  with  affinity-purified anti-lamin  antibodies  (not 
shown) except that with anti-lamin antibodies, nuclear rim 
staining was demonstrable. 
In contrast with third instar larval tissues (Fig. 6) and adult 
head cryosections, topo II was not identifiable in most adult 
Drosophila muscle cell nuclei (Fig. 7, d-f).  When similar 
muscle preparations were stained with affinity-purified  anti- 
lamin antibodies, muscle cell nuclear staining was readily 
3. Immunocytochemical detection of mammalian PCNA is complicated by 
the observation that in non-S-phase  cells under certain conditions of fixation 
(methanol), it is undeteetable in situ, despite the fact that it can be readily 
identified by immunoblot analysis of the same cells or tissue. Other fixation 
conditions apparently  facilitate in  situ  detection of mammalian PCNA 
whenever it is present (see, for example, Bravo and Macdonald-Bravo, 
1987).  In our analyses, we have used only those fixation conditions under 
which PCNA is detectable, regardless of cell cycle position. 
The Journal  of Cell Biology,  Volume 112, 1991  208 Figure 6. In situ localization of  topo II and PCNA in Drosophila third instar larval tissues.  Phase contrast (a, d, and g), immunofluorescence 
(b, e, and h),  and DAPI fluorescence (c, f, and i) micrographs. Specimen in a-c, a cryoscction through the third instar larval imaginal 
disc tissue,  was probed with affinity-purified anti-Drosophila  topo II IgG at a final concentration of about 1 #g/ml followed by rhodamine- 
conjugated donkey anti-rabbit IgG. Specimen in d-f a squash preparation from third instar larval neural ganglion tissue, was probed simi- 
larly to the specimen in a-c. Specimen in g-i, a squash preparation identical to that shown in d-f, was probed with affinity-purified  anti- 
Drosophila PCNA IgG at a final concentration of '~ 2 #g/ml followed by rhodamine-conjugated donkey anti-rabbit IgG. Preimmune serum 
from both rabbits  gave no detectable immunofluorescence on these specimens (not shown; see McConnell et al.,  1987; Ng et al.,  1990). 
Bar,  10/~m. 
Whalen et al. Developmental  Regulation of topo H  209 Figure 7. In situ localization of tope II and lamin in Drosophila adult muscle squashes. Phase-contrast (a and d), immtmofluorescence 
(b and e), and DAPI fluorescence (c and f) micrographs.  The specimen in a-c was probed with affinity-purified anti-Drosophila lanim 
IgG at a final concentration of ,~1/tg/ml followed by rhodamine-conjugated donkey anti-rabbit  IgG. The specimen in d-f  was probed with 
a similar concentration of  afffinity-purified  anti-Drosophila topo II IgG followed similarly by rhodamine-conjugatad donkey anti-rabbit IgG. 
Bar, 10/~m. 
demonstrable (Fig. 7, a-c). However, muscle cell anti-lamin 
antibody  nuclear  staining  was  rela~vely  weak  compared 
with  staining  of other  nonmuscle  cell nuclei  in the  same 
specimen  (Fig.  7  b).  This  may be particularly  significant 
in  that  both  types of nuclei  stained  Similarly  with  DAPI 
(Fig.  7 c). 
i 
Identification of  a Soluble Pool of topo!  H Early 
in Embryogenesis 
Recently, we reported that a soluble pool of nuclear lamin 
was present in early embryos that was apparently  derived 
from germinal vesicle breakdown at the final stage of oogen- 
esis (Smith and Fisher, 1989). To determine whether a simi- 
lar pool of topo H was present in early embryos, immunoblot 
analyses were performed after cell fractionation to separate 
nuclear  pellets from post-nuclear  supernatants  at different 
time points of embryogenesis. The results of these experi- 
ments (Fig.  8) indicated that for both topo II (Fig. 8 A) and 
lamin (Fig. 8 B), there was a soluble pool of antigen present 
at the earliest time point when no nuclear antigen was detect- 
able (compare Fig. 8, A and B, lanes e with lanes i). In the 
case of lamin,  this  antigen  was in the  single lamin  Drn~, 
isoform, characteristic of cells that have undergone nuclear 
envelope breakdown either during meiosis or mitosis (Smith 
and Fisher,  1989;  Lin and Fisher,  1990). 
At later time points of embryogenesis, topo II as well as 
lamin appeared in the nuclear pellet fraction (Fig.  8, A and 
B, lanes j,  k,  and l).  Both interphase  lamin  isoforms Dm~ 
and Din2 (Smith et al.,  1987) were present (Fig.  8 B, lanes 
j,  k  and  l).  In the case of lamin,  accumulation  of lamins 
Dm~ and Dm: in the nuclear pellet fraction through devel- 
opment correlated with loss of soluble lamin Dn~, (Fig.  8 
B, compare lanes i-l with lanes e-h, respectively). In con- 
trast,  for topo II,  both nuclear and apparently nonnuclear 
forms were identified at later time points (Fig. 8 A, compare 
lanes j, k, and I with lanes f, g, and h, respectively). In situ 
analyses (not shown) suggest that in vivo, all topo H is nu- 
clear in late embryonic cells during interphase. We therefore 
think it likely that the apparently nonnuclear pool of topo II 
present at later time points of embryogenesis (Fig. 8 A, lanes 
g  and h) is in reality, an extractable nuclear pool. 
The Journal  of  Cell  Biology,  Volume 112,  1991  210 Figure 8. Identification of soluble and pelletable isoforms of topo 
II and lamin during Drosophila embryoganesis.  SDS-7  % PAGE  and 
immtmoblot  analyses were performed as described (Materials and 
Methods) on total embryo homogenates (T, lanes a-d),  10,000 g 
homogenate supematants ($, lanes e-h), and 10,000 g homogenate 
pellet fractions (P, lanes i-l). Equivalent aliquots, 4 U (Fisher et 
al., 1982), were loaded in each lane. I.ames  a, e, and i, 0-3-h-old 
embryos; lanes b, f, and j, 6-9-h-old embryos; lanes c, g, and k, 
12-15-h-old embryos; lanes d, h, and 1, 19-22-h-old embryos. Im- 
munoblot shown in d was probed with anti-Drosophila topo II an- 
tiserum diluted 1:1,000. The entire blot is shown. Identical results 
were obtained with affinity-purified  anti-topo II antibodies (not 
shown). Immunoblot shown in B was probed with affinity-purified 
anti-Drosophila lamin antibodies. Only the region of primary im- 
munoreactivity is shown. 
Discussion 
In vertebrates, topo II is apparently regulated during the cell 
cycle. After mitosis, much of it is rapidly degraded only to 
be resynthesized in actively proliferating cells in late G~ or 
early S phase (Heck et al., 1988). In cells that stop prolifer- 
ating, topo II disappears and resting cells, i.e., those in phase 
Go of the cell cycle, apparently lack topo II entirely (Heck 
and  Earnshaw,  1986)?  Despite  earlier  suggestions  that 
Drosophila topo II behaved similarly as deduced from de- 
velopmental analyses (Fairman and Brutlag,  1988),  results 
reported in this article indicate otherwise. 
Although in current  experiments,  wide  fluctuations of 
topo II levels were seen through development in Drosophila, 
these fluctuations were paralleled by similar changes in nu- 
clear lamin levels at all stages but in the adult males. An in- 
ternal standard nuclear protein such as lamin was not ana- 
lyzed in the earlier  study (Fairman  and Brutlag,  1988). 
Drosophila topo II mRNA levels also fluctuated  more or less 
in parallel with lamin mRNA levels; the most significant 
difference  between the two was seen early in embryogenesis. 
In this respect, we agree with the findings of Fairman and 
Brutlag  (1988).  Indeed,  these  authors  suggested that the 
large pool of  topo II message seen in early embryos was most 
likely maternally derived, yet they saw no evidence of this 
pool in adults. In contrast, we detected topo II mRNA in both 
male and female adults. Consistent with the suggestion of 
Fairman and Brutlag (1988) regarding the maternal origins 
of the topo II mRNA found in early embryos, we found that 
adult females contained much more topo II message than 
adult males (Fig. 4  C). 
Also in contrast with the results of Fairman and Brutlag 
0988), we found topo II protein present at all developmental 
stages and saw little evidence of the proteolytic breakdown 
products reported by them, particularly late in embryogene- 
sis (compare Fig. 4 of Fairman and Brutlag 0988) with Fig. 
8 A, lane d). In this respect, our results agree with those of 
Hadlaczky et al. 0988) who found using monoclonal anti- 
bodies, that topo II was detectable as an undegraded 166-kD 
polypeptide throughout embryogenesis, in pupae, adult fly 
heads, and Schneider $3 tissue culture cells. A single 38-kD 
polypeptide, identified by these authors and suggested to be 
a  stable in vivo breakdown product of Drosophila  topo II 
(Hadlaczky et ed., 1988),  was not noted in our experiments 
(see also Fig. 5 of Ng et al.,  1990). 
Results of immunoblot analyses, which form the basis for 
many of our current conclusions, were corroborated and ex- 
tended by in situ studies. In these experiments, we compared 
the distribution of  topo II with that of  both lamin and PCNA. 
topo II was detectable in virtually every cell in a variety of 
Drosophila larval and adult tissues by immunocytochemical 
analyses using affinity-purified anti-topo II antibodies. The 
exception to this was adult muscle where topo H was not de- 
tected. This pattern of distribution was relatively similar to 
that seen for lamin which was detected in every cell type ex- 
amined, including muscle and was quite different from that 
of PCNA. PCNA was only seen in a small minority of those 
cells analyzed; as reported elsewhere, this correlated with an 
entirely different pattern of expression through Drosophila 
embryogenesis revealed by immunoblot analysis (see Fig. 5 
ofNg et al., 1990). In this context, it may also be noteworthy 
that recent studies of cell cycle regulation of yeast topo H 
failed to uncover evidence for significant decreases in topo 
II levels in nondividing cells (Cardenas et al.,  1990). 
How can we reconcile the results reported in this article 
with those from comparable studies of vertebrate systems 
4. These  results  are consistent  with  a number  of  other studies  of vertebrate 
topo II (see, for example, Hsiang  et al., 1988). 
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sidering trivial explanations, we think it highly unlikely that 
our results are attributable to lack of antibody specificity. 
Similar immunochemical and immunocytochemical results 
were obtained  with  each of two different anti-Drosophila 
topo II antisera,  as well as with antibodies affinity purified 
using as the affinity ligand, either authentic topo II purified 
from  Drosophila embryos  or  clone-encoded  Drosophila 
topo II expressed in bacteria. This last population of antibod- 
ies was used for all of the in situ analyses presented in this 
article.  In addition,  our results regarding the identification 
of Drosophila topo II in nonproliferating cells are in agree- 
ment with those of Hadlaczky et al.  (1988) obtained with 
monoclonal antibodies. 
It  is  possible  that  despite  our  efforts  to  identify  non- 
proliferating cells from Drosophila, none except those from 
adult muscle were truly in phase Go of the cell cycle,  fin 
this context, it is perhaps noteworthy that the differentiating 
myoblast system was one in which vertebrate topo II was 
seen to disappear [Heck and Earnshaw,  1986].) This possi- 
bility cannot be excluded.  However, the very different be- 
havior of Drosophila  PCNA as revealed both by immunoblot 
analyses (Ng et al.,  1990) and in situ (Fig. 6), indicates that 
at the very least, topo II cannot be used as a specific marker 
for cell proliferation in Drosophila as has been proposed for 
vertebrates (Heck and Earnshaw,  1986). 
We are left therefore with two possible explanations for the 
differences observed between Drosophila and vertebrates. 
The first which, though not very satisfying, must be consid- 
ered, is that Drosophila  is fundamentally different from ver- 
tebrates with respect to regulation of topo II and/or the cell 
cycle.  The tendency of Drosophila chromosomes to poly- 
tenize in terminally differentiated tissues may be of relevance 
in this regard.  The second possibility was proposed previ- 
ously  (Fisher,  1989)  and  is  suggested  by  the  recent 
identification  of two immunologically  and genetically dis- 
tinct mammalian topo II isozymes (Drake et al., 1987, 1989; 
Chung et al.,  1989). If these observations are generally ap- 
plicable  to vertebrates  and the  antibodies  used by others 
(Heck and Earnshaw,  1986; Heck et al.,  1988; Heck et al., 
1989) to study cell cycle regulation of topo II were specific 
for only one of these isozymes, patterns of expression of the 
other isozyme may have gone unrecognized. Drosophila on 
the other hand, might have only one topo II isozyme, or al- 
ternatively, anti-Drosophila  topo II antibodies might not dis- 
tinguish  among  different  isozymes.  In  either  instance,  a 
different pattern of topo II regulation in Drosophila relative 
to vertebrates might be revealed; such differences could well 
be more apparent than real. 
Throughout this article, we compared topo II with nuclear 
lamin. An underlying motive in performing this comparison 
was to test the hypothesis that topo II was a karyoskeletal 
protein analogous with lamin. Although the results obtained 
do not address this question directly, we feel that the experi- 
ment documented in Fig. 8 is relevant. The presence of large 
soluble pools of both larnin and topo II early in embryogene- 
sis, presumably derived from germinal vesicle breakdown at 
the end of oogenesis, suggests that the solubility of topo II 
in vivo can be regulated in a manner comparable to that of 
lamins.  Similar  behavior  of Xenopus topo  11  has  been 
reported (Luke and Bogenhagen,  1989). 
Adachi et al. (1989) demonstrated the ability of S. pombe 
topo II to bind cooperatively to plasmids containing specific 
DNA-scaffold attachment site sequences and upon so doing, 
to  form  supramacromolecular  aggregates.  We as  well  as 
others demonstrated that purified lamins can assemble into 
filaments ("aggregate")  in vitro (Aebi et al.,  1986; Lin and 
Fisher, 1990). Moreover, we showed that only lamin isolated 
from interphase nuclei was capable of in vitro self-assembly; 
the soluble form found in early embryos was unable to do 
so (Lin and Fisher,  1990). By analogy, it may be that only 
the form of topo II isolated from interphase nuclei is able to 
participate  in  structural  interactions  necessary  to  form 
supramacromolecular aggregates. Direct comparison of the 
interphase nuclear form of Drosophila topo II with the solu- 
ble form found in early embryos may thus lead to explicit in- 
sights  regarding  the  biological  significance  of aggregates 
such as those reported by Adachi et al. (1989) and hence, the 
potential role of topo II as a karyoskeletal protein. 
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